Company or institution

Agios Pharmaceuticals, Inc.

Save Like

142 applicationsfiled 2010 to 2026

Allowance rate

76%

+1 pts vs the USPTO range 68% to 83%

Rejections before allowance

1.4

−0.2 vs the USPTO

Months to first action

11.0 mo

−7.6 vs the USPTO

Needed an RCE

27%

level with the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations75 apps

C07D Heterocyclic compounds47 apps

A61P Therapeutic activity of compounds9 apps

G16H Healthcare informatics3 apps

C12Q Measuring or testing processes involving enzymes or nucleic acids3 apps

G01N Investigating or analysing materials3 apps

Art units

162437 apps

162920 apps

162515 apps

162111 apps

162610 apps

162710 apps

Examiners met

The examiners seen most, and how it went with each

Venkataraman Balasubramanian13 apps

100%

Raymond J Henley III11 apps

91%

Brenda Libby Coleman6 apps

83%

Gregg Polansky6 apps

83%

Kahsay Habte6 apps

83%

Samira Jm Jean-Louis5 apps

80%

Fred H Reynolds5 apps

40%

Michael J Schmitt5 apps

20%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

GOODWIN PROCTER LLP/AGIOS42 apps

83%

GOODWIN PROCTER LLP31 apps

77%

McCarter & English / Agios Pharmaceuticals29 apps

82%

Jones Day25 apps

76%

BakerHostetler6 apps

67%

CELGENE CORPORATION2 apps

100%

HOFFMAN WARNICK LLC2 apps

MCCARTER & ENGLISH, LLP BOSTON2 apps

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19651139	METHODS OF USING PYRUVATE KINASE ACTIVATORS	2026-04-17	Pending	0	0	n/a
19629456	CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOL…	2026-03-26	Pending	0	0	n/a
19556112	COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS	2026-03-04	Allowed	1	0	1.5 mo
15216570	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15833493	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15176199	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15582852	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15710256	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15998808	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15588108	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 142 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in